Sue Bailey is Director at Emergent BioSolutions Inc. (EBS). They have made 14 open-market trades across 1 company since 2009, most recently 2021-03-04.
CIK 0001403769
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EBS | 24,427 | $156K |
Shares reported on the most recent Form 4, priced at the 2021-03-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EBS | SELL | 2021-03-04 | 2021-03-08 | $92.37 | $1.5M | +0.7% | -10.0% | -25.3% |
| EBS | SELL | 2020-08-18 | 2020-08-19 | $128.31 | $1.2M | -11.8% | -22.2% | -34.0% |
| EBS | SELL | 2020-06-03 | 2020-06-05 | $87.50 | $466K | -6.8% | +14.3% | +42.6% |
| EBS | SELL | 2020-02-27 | 2020-03-02 | $56.93 | $748K | -3.6% | -6.9% | +52.9% |
| EBS | SELL | 2019-12-12 | 2019-12-13 | $53.46 | $895K | +3.9% | +4.5% | +7.8% |
| EBS | SELL | 2018-11-27 | 2018-11-29 | $69.62 | $1.2M | -9.7% | -17.1% | -17.9% |
| EBS | SELL | 2018-11-27 | 2018-11-29 | $69.62 | $2.5M | -9.7% | -17.1% | -17.9% |
| EBS | SELL | 2017-01-17 | 2017-01-19 | $29.78 | $296K | +3.2% | +2.3% | -2.0% |
| EBS | SELL | 2017-01-17 | 2017-01-19 | $29.78 | $593K | +3.2% | +2.3% | -2.0% |
| EBS | SELL | 2016-01-04 | 2016-01-06 | $38.79 | $447K | -12.1% | -4.7% | +0.1% |
| EBS | SELL | 2016-01-04 | 2016-01-06 | $38.79 | $447K | -12.1% | -4.7% | +0.1% |
| EBS | SELL | 2015-09-11 | 2015-09-15 | $32.37 | $197K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2015-05-12 | 2015-05-14 | $30.12 | $600K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2009-09-11 | 2009-09-15 | $19.21 | $192K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2009-03-11 | 2009-03-13 | $16.59 | $119K | -12.7% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.